These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23668989)

  • 21. Identification of high-affinity P2Y₁₂ antagonists based on a phenylpyrazole glutamic acid piperazine backbone.
    Zech G; Hessler G; Evers A; Weiss T; Florian P; Just M; Czech J; Czechtizky W; Görlitzer J; Ruf S; Kohlmann M; Nazaré M
    J Med Chem; 2012 Oct; 55(20):8615-29. PubMed ID: 22984835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists.
    Biju P; Taveras A; Yu Y; Zheng J; Chao J; Rindgen D; Jakway J; Hipkin RW; Fossetta J; Fan X; Fine J; Qiu H; Merritt JR; Baldwin JJ
    Bioorg Med Chem Lett; 2008 Jan; 18(1):228-31. PubMed ID: 18006311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-alkyl-1,3-oxazole derivatives of 6-amino-nicotinic acids as alkyl ester bioisosteres are antagonists of the P2Y12 receptor.
    Bach P; Boström J; Brickmann K; Burgess LE; Clarke D; Groneberg RD; Harvey DM; Laird ER; O'Sullivan M; Zetterberg F
    Future Med Chem; 2013 Nov; 5(17):2037-56. PubMed ID: 24215345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanism of action for reversible P2Y12 antagonists.
    Liu H; Ge H; Peng Y; Xiao P; Xu J
    Biophys Chem; 2011 May; 155(2-3):74-81. PubMed ID: 21440362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiadiazole-a promising structure in medicinal chemistry.
    Li Y; Geng J; Liu Y; Yu S; Zhao G
    ChemMedChem; 2013 Jan; 8(1):27-41. PubMed ID: 23208773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New P2Y₁₂ inhibitors.
    Storey RF
    Heart; 2011 Aug; 97(15):1262-7. PubMed ID: 21742618
    [No Abstract]   [Full Text] [Related]  

  • 27. ADP ribose is an endogenous ligand for the purinergic P2Y1 receptor.
    Gustafsson AJ; Muraro L; Dahlberg C; Migaud M; Chevallier O; Khanh HN; Krishnan K; Li N; Islam MS
    Mol Cell Endocrinol; 2011 Feb; 333(1):8-19. PubMed ID: 21094205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium dependence of purinergic subtype P2Y₁ receptor modulation of C6 glioma cell migration.
    Jantaratnotai N; McLarnon JG
    Neurosci Lett; 2011 Jun; 497(2):80-4. PubMed ID: 21540076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential histamine H2-receptor antagonists. Synthesis, conformational studies and activity of novel 3-oxo-1,2,5-thiadiazole 1,1-dioxide derivatives.
    Arán VJ; Dávila E; Francés M; Goya P; Gras J; Martínez A; Mylonakis N; Pardo I
    Arzneimittelforschung; 1990 Sep; 40(9):1003-7. PubMed ID: 1981968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New 5-(nitroheteroaryl)-1,3,4-thiadiazols containing acyclic amines at C-2: synthesis and SAR study for their antileishmanial activity.
    Tahghighi A; Emami S; Razmi S; Rezazade Marznaki F; Kabudanian Ardestani S; Dastmalchi S; Kobarfard F; Shafiee A; Foroumadi A
    J Enzyme Inhib Med Chem; 2013 Aug; 28(4):843-52. PubMed ID: 22651800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of 2-(4-((1H-1,2,4-triazol-1-yl)methyl)-5-(4-bromophenyl)-1-(2-chlorophenyl)-1H-pyrazol-3-yl)-5-tert-butyl-1,3,4-thiadiazole (GCC2680) as a potent, selective and orally efficacious cannabinoid-1 receptor antagonist.
    Lee J; Seo HJ; Lee SH; Kim J; Jung ME; Lee SH; Song KS; Lee J; Kang SY; Kim MJ; Kim MS; Son EJ; Lee M; Han HK
    Bioorg Med Chem; 2010 Sep; 18(17):6377-88. PubMed ID: 20673729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diarylimidazolyl oxadiazole and thiadiazole derivatives as cannabinoid CB1 receptor antagonists.
    Kim JY; Seo HJ; Lee SH; Jung ME; Ahn K; Kim J; Lee J
    Bioorg Med Chem Lett; 2009 Jan; 19(1):142-5. PubMed ID: 19022666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling.
    Schweigel H; Geiger J; Beck F; Buhs S; Gerull H; Walter U; Sickmann A; Nollau P
    Proteomics; 2013 Mar; 13(6):1016-27. PubMed ID: 23322602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and anti-Helicobacter pylori activity of 5-(nitroaryl)-1,3,4-thiadiazoles with certain sulfur containing alkyl side chain.
    Foroumadi A; Rineh A; Emami S; Siavoshi F; Massarrat S; Safari F; Rajabalian S; Falahati M; Lotfali E; Shafiee A
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3315-20. PubMed ID: 18442909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a series of potent arylthiadiazole H(3) antagonists.
    Xiao D; Palani A; Sofolarides M; Huang Y; Aslanian R; Vaccaro H; Hong L; McKittrick B; West RE; Williams SM; Wu RL; Hwa J; Sondey C; Lachowicz J
    Bioorg Med Chem Lett; 2011 Jan; 21(2):861-4. PubMed ID: 21186123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of thiadiazole amides as potent, S1P₃-sparing agonists of sphingosine-1-phosphate 1 (S1P₁) receptor.
    Xu H; Zhang H; Luan L; Xu Y; Li C; Wang Y; Han F; Yang T; Ren F; Xiang JN; Elliott JD; Zhao Y; Guo TB; Lu H; Zhang W; Hirst D; Lindon M; Lin X
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2456-9. PubMed ID: 22386243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.
    Hilfiker MA; Wang N; Hou X; Du Z; Pullen MA; Nord M; Nagilla R; Fries HE; Wu CW; Sulpizio AC; Jaworski JP; Morrow D; Edwards RM; Jin J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4292-5. PubMed ID: 19487124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P2X and P2Y nucleotide receptors as targets in cardiovascular disease.
    Kennedy C; Chootip K; Mitchell C; Syed NI; Tengah A
    Future Med Chem; 2013 Mar; 5(4):431-49. PubMed ID: 23495690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of ticagrelor derivatives as novel antiplatelet agents.
    Zhang H; Liu J; Zhang L; Kong L; Yao H; Sun H
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3598-602. PubMed ID: 22546677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological characterization of purinergic inhibitory neuromuscular transmission in the human colon.
    Gallego D; Gil V; Aleu J; Martinez-Cutillas M; Clavé P; Jimenez M
    Neurogastroenterol Motil; 2011 Aug; 23(8):792-e338. PubMed ID: 21585621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.